Quick Answer
Oncology Institute, Inc. reported Long-Term Debt of $77.40 million for fiscal year 2025.
Oncology Institute, Inc. Long-Term Debt — Annual History
| Fiscal Year | Long-Term Debt | YoY Change |
|---|---|---|
| 2025 | $77.40M | -16.9% |
| 2024 | $93.13M | +7.3% |
| 2023 | $86.83M | +7.7% |
| 2022 | $80.62M | — |
| 2021 | $0.00 | -100.0% |
| 2020 | $6.56M | — |
Quarterly Long-Term Debt
| Quarter Ending | Long-Term Debt | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $76.19M | -16.8% | +1.6% |
| June 30, 2025 | $75.02M | -16.6% | +1.5% |
| March 31, 2025 | $73.89M | -16.4% | -20.7% |
| December 31, 2024 | $93.13M | +7.3% | +1.7% |
| September 30, 2024 | $91.54M | +7.4% | +1.8% |
| June 30, 2024 | $89.95M | +7.5% | +1.8% |
| March 31, 2024 | $88.39M | +7.6% | +1.8% |
| December 31, 2023 | $86.83M | +7.7% | +1.8% |
- Oncology Institute, Inc. showed a decrease of -16.9% in Long-Term Debt compared to the prior fiscal year.
- Over the 2020–2025 period, Oncology Institute, Inc.’s long-term debt has grown by 1079.7% (from $6.56 million to $77.40 million).
- The most recent figure is from Oncology Institute, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 12, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: